NCN Europe Investor Meeting 2017
Zaluvida Innovation Partnering Meeting 2016
NOTE: Application deadline extended to September 10, 2016!
Global life science group Zaluvida and Nutrition Capital Network are collaborating on an Innovation Partnering Meeting to introduce investment, collaboration and partnering prospects to senior executives of Zaluvida.
Zaluvida is headquartered in Malaysia and Switzerland, and has a full span of operating units including consulting & clinical research (analyze & realize, Berlin, Germany), Biotech (e.g. Neem Biotech, Wales, UK) and human/animal health R&D and commercialization (InQpharm/InQVet, Asia, Europe, US).
The Zaluvida Innovation Partnering Meeting 2016 is a 1.5-day event September 28-29, 2016 hosted by Zaluvida in Berlin, Germany, where a select group of companies will learn about working with Zaluvida, and present their business plans to the team for consideration.
Zaluvida has a proven track record of partnering with inventors, entrepreneurs, universities and life science companies to accelerate and increase the scale of innovation & commercialization of bioactive compounds and technologies.
The Zaluvida ecosystem allows for a broad range of cooperation models: from co-development to in-licensing and from direct investment to full acquisition.
Case Study: Zaluvida-Neem Biotech -- Michael Graz PhD, Managing Director of Neem:
"Neem has grown rapidly and smoothly since our relationship with Zaluvida started in 2012.... Zaluvida has consistently provided a valuable resource to our work strategically, financially and in scientific support from the CSO and his group.... As a financial and strategic partner it is clear that their objectives match ours. Their understanding of the culture of our company has meant that they allowed us the space to carry out our work whilst keeping a keen interest in our activities. This has meant that we have been able to successfully navigate into the world of drug development for rare diseases and the unmet medical needs of today’s society."
Apply to be a presenting company
Zaluvida is a full circle life science group. Our passion is creating ground breaking health products. By using unique bioactive compounds extracted from nature we pioneer in tackling some of the world’s big health challenges like obesity, antibiotic resistance and livestock emissions. Our teams are united by the desire to use our continuous visionary biotech innovations to help shaping a better future for as many people in the world as possible. Our products range from market leading easy-to-use weight management solutions, new ways to help cystic fibrosis patients, to stunning new respiratory allergy cures and much more. Furthermore we develop and distribute animal health products and feed supplements. Some of them help to reduce the need of antibiotics to raise livestock. All of them address big global health issues! The Zaluvida group operates on a global level and consists of cutting-edge life science companies, active across the entire value chain. To give back and support people beyond our products Zaluvida has founded the Zaluvida Foundation, which actively supports the NGO Healthnet TPO by being its main financial constituent, as well as driving Community Care programs in all of Zaluvida’s locations around the globe.
Key Targets and Search Criteria for the 2016 Innovation Partnering Meeting:
Ingredients, products or technologies
Strategic fit with Zaluvida’s health focus areas
Strong market potential and unmet need
Novel or unique or clear differentiation from market products/competitors
Strong communicable benefits
Patent protection preferred, and/or exclusive access
Proof of concept data support for efficacy
Basic data available for indication of safety
Areas of interest include:
Natural or naturally derived compounds for:
Oral health (e.g., halitosis, desensitization, remineralisation, restoration of normal flora, whitening)
Revitalisation (healthy nutrition for cellular functions and energy production)
Detoxification (removal of waste and toxins and regeneration of bodily functions)
Brain health (improving cognitive functions such as alertness and memory)
Joint health for improved mobility
Animal health (Natural or naturally derived compounds for livestock animals, particularly antiinfections)
Antimicrobial for rare diseases or resistant microbes
Consumer health – wound care application
Orphan drug for rare diseases, e.g., cystic fibrosis
Compounds for tree diseases
Formulation or delivery technologies
Other innovative ingredients/technologies beside the key target areas above may also be considered, e.g., portable and smart wearable devices for healthcare
Apply to be a presenting company
EVENT AGENDA: Berlin, Germany
Wednesday, 28 September, 2016
4:00 to 6:00 pm:
Meeting Overview and Welcome
Introduction to Zaluvida: Investment Thesis
Operations, Marketing strategy, Research and development
Presentation by Dr. Volker Spitzer VP Consulting & Strategic Innovation at analyze & realize
(formerly Roche, DSM & Bayer Consumer Health)
Topic: Consumer and product trends in natural health and nutrition
6:00 pm: Cocktail hour (Location TBD)
Thursday, 29 September, 2016
8:30 to 9:00 am: Objectives and recap: All
(Note: Presenting companies will have lounge or workspace during the other company presentations.)
9:00 am to 12:00 pm: 6 company presentations (~20 minutes per presentation with 10 minutes for Q&A and transition between presenters)
12:00 to 1:00 pm: Lunch for all
1:00 to 4:00 pm: 2-4 company presentations (~20 minutes per presentation with 10 minutes for Q&A and transition between presenters)
4:00 to 4:30 pm: Internal Review ; summary and next steps
5:30 pm Cocktail Party with all Zaluvida and company participants.